Previous Posts
- This blog has moved
- Avandia Given Positive Reviews Due to $$$$$?
- The FDA and Drug Approval
- J&J Planned Profit from Risky, Unapproved Uses of ...
- What Are the Different Classes of Drug Recalls?
- What Is the Difference Between Class Action and Mu...
- First Lawsuit for Avandia Filed In Santa Clara Cou...
- Our Involvement in the Yaz®/Yasmin® Litigation
- What Is An FDA Black Box Warning?
- What Is a Drug Recall?
Archives
- April 2008
- May 2008
- May 2009
- June 2009
- July 2009
- August 2009
- September 2009
- October 2009
- November 2009
- December 2009
- January 2010
- February 2010
- March 2010
- April 2010
Click Here to View
Our Other Site
Thursday, October 22, 2009
Penumbra Neuron 5F Select Catheter Recall
The Food and Drug Administration (FDA) and Penumbra Inc. notified healthcare workers that they had begun to initiate a Class I recall of the Neuron 5F Select Catheter on May 29, 2009. This catheter is used to remove blood clots or foreign objects from blood vessels. It was manufactured in late May and distributed through June 12.
The FDA and Penumbra Inc. have stated the reason for the recall as a manufacturing error. According to the FDA medical device recall announcement, the Neuron 5F "may contain pin holes and exposed wire braids which may result in a brain clot or a blood vessel puncture, and this may lead to possible death."
The FDA further states that all defective catheters were returned to Penumbra Inc. and destroyed.
A Class I recall is the most serious type of recall the FDA announces. This means there is a reasonable probability that the product, like the Penumbra Neuron catheter, will cause injury or death.
The FDA has asked healthcare professionals and consumers to report adverse reactions or other problems with the Neuron 5F Select Catheter to the FDA's MedWatch Adverse Even Reporting Program. You may also contact Penumbra, Inc. at 510-618-3223.
If you or your loved one has been injured by the Neuron 5F Select Catheter or another defective medical device, please contact the experienced personal injury attorneys at Schlichter, Bogard & Denton. We serve clients nationwide.
posted by
Erica
at
9:39 AM
Wednesday, October 7, 2009
Yaz/Yasmin/Ocella MDL transferred to Southern District of Illinois
The Judicial Panel found the Southern District of Illinois will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. U.S. District Court Judge David R. Herndon will preside over these Yaz and Yasmin cases for coordinated or consolidated pretrial proceedings. All consolidated actions share factual questions relating to at least one of the drospirenone-containing oral contraceptives Yaz and Yasmin, which are manufactured by Bayer. Plaintiffs in the products liability actions challenge the safety of those oral contraceptives and bring claims for personal injuries or wrongful death stemming from use of the drugs.
Yaz and Yasmin, as well as the generic Ocella, have been associated with various serious side effects, including Blood Clots, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Stroke, Cerebrovascular Accidents (CVA), Heart Attack, Myocardial Infarction, Gallbladder Disease / Injury, Gallbladder Removal (cholecystectomy), Kidney Failure or Renal Failure, Pancreatitis and even Death.
posted by
Megan M. McBride
at
4:26 PM